Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AAAMA70269
Vitamine K2 + D3, Extrapuissante, 120 capsules
midtail
3P
MEDICAMENTS
Last 4 weeks demand
11
▲ 57.1% vs prev 4w
Offer Stock
30
Σ Stock across 6 live offers (1P + 3P) · 2026-08-05
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-08-05 snapshot
Unit price
MAD 301
avg of last 30 sells · latest 2026-08-02
AAAMA70269
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-08-03 · Total forecast: 159 units.
Actual
Realistic forecast
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Vitamine K2 + D3, Extrapuissante, 120 capsules · in the midtail cohort · last 4 weeks 11 units, trending up +57.1% · on-hand 23 units
Signals the model saw
- Cohort: midtail (623 days of history, 311 units sold over 52 weeks)
- Volatility (CV): 0.84 — moderate
- Recent trend: last 4w = 11 units · prev 4w = 7 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 3.7 units |
| Realistic forecast — next 4 weeks | 16.9 units |
| Realistic forecast — next 3 months | 74.0 units |
| Optimistic — next week | 7.1 units |
| Optimistic — next 4 weeks (reorder target) | 33.5 units |
| Optimistic — next 3 months (quarterly PO target) | 158.8 units |
| Legacy μ/wk (reorder pipeline) | 3.4 |
| Revenue exposure — optimistic, 3 months | MAD 47.9K |